Cat. No.: DIA-0230307
Product Information | |
---|---|
CAS No. | 501919-59-1 |
Synonyms | NSC 74859 |
Formula | C16H15NO7S |
Molecular Weight | 365.36 |
SMILES | CC1=CC=C(C=C1)[S](=O)(=O)OCC(=O)NC2=CC=C(C(O)=O)C(=C2)O |
Product Description | S3I-201 shows potent inhibition of STAT3 DNA-binding activity with IC50 of 86 μM in cell-free assays, and low activity towards STAT1 and STAT5. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.